Tevogen Bio Holdings INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Tevogen Bio Holdings seeks to register the resale of common stock and warrants, potentially raising $207 million through warrant exercises for general corporate purposes.
NASDAQ
Tevogen Bio Holdings Inc. is amending its S-1 registration statement to include details on the issuance and resale of common stock and warrants, aiming to raise capital for general corporate purposes.
NASDAQ
Tevogen Bio Holdings seeks to register the resale of a substantial number of common shares and warrants, potentially impacting its stock price.